Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2021Journal of Clinical InvestigationOpen Access

First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAlessio MazzoniAzienda Ospedaliero-Universitaria CareggiNLNicoletta Di LauriaAzienda Ospedaliero-Universitaria CareggiLMLaura MaggiUniversity of Florence

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mazzoni et al. (2021) studied this question.

synapsesocial.com/papers/6a76c35698f24dbf64bd5380https://doi.org/10.1172/jci149150
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection2021 · 3,030 citations
  2. 2Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK2020 · 5,024 citations
  3. 3The Untold Toll — The Pandemic’s Effects on Patients without Covid-192020 · 725 citations
  4. 4What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors2020 · 221 citations
  5. 5Covid-19 — Implications for the Health Care System2020 · 52 citations